etodolac has been researched along with Gastric Diseases in 4 studies
Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.
| Excerpt | Relevance | Reference |
|---|---|---|
| "World-wide experience with nimesulide confirms that it is an effective anti-inflammatory drug in the treatment of osteoarthritis." | 8.81 | Nimesulide, a balanced drug for the treatment of osteoarthritis. ( Huskisson, EC, 2001) |
| "World-wide experience with nimesulide confirms that it is an effective anti-inflammatory drug in the treatment of osteoarthritis." | 4.81 | Nimesulide, a balanced drug for the treatment of osteoarthritis. ( Huskisson, EC, 2001) |
| "To evaluate adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs." | 2.73 | Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs. ( Basílio, AC; Brandão, CV; Luna, SP; Machado, LP; Moutinho, FQ; Steagall, PV; Takahira, RK, 2007) |
| "Some adaptation occurred in over 90% of subjects after 4 weeks dosing with an NSAID, but adaptation was less frequent in older subjects and in smokers." | 1.30 | The influence of age, gender, Helicobacter pylori and smoking on gastric mucosal adaptation to non-steroidal anti-inflammatory drugs. ( Campbell, F; Lipscomb, GR; Rees, WD, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanbayashi, Y | 1 |
| Konishi, H | 1 |
| Luna, SP | 1 |
| Basílio, AC | 1 |
| Steagall, PV | 1 |
| Machado, LP | 1 |
| Moutinho, FQ | 1 |
| Takahira, RK | 1 |
| Brandão, CV | 1 |
| Lipscomb, GR | 1 |
| Campbell, F | 1 |
| Rees, WD | 1 |
| Huskisson, EC | 1 |
1 review available for etodolac and Gastric Diseases
| Article | Year |
|---|---|
Nimesulide, a balanced drug for the treatment of osteoarthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Diclofenac; Etodolac; Humans; Nap | 2001 |
1 trial available for etodolac and Gastric Diseases
| Article | Year |
|---|---|
Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Coagulation; Carbazole | 2007 |
2 other studies available for etodolac and Gastric Diseases
| Article | Year |
|---|---|
Predictive Factors for NSAIDs-related Gastrointestinal Toxicity: Can COX-2 Selective Inhibtor Prevent it?.
Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antineoplast | 2015 |
The influence of age, gender, Helicobacter pylori and smoking on gastric mucosal adaptation to non-steroidal anti-inflammatory drugs.
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Tole | 1997 |